Oral Fingolimod (FTY720) Treatment Improves the Performance of Daily Activities Compared with Intramuscular Interferon beta-1a: Patient-Reported Indices for Multiple Sclerosis (PRIMUS)-Activities Results from a Phase III Study (TRANSFORMS)

J. Cohen; F. Barkhof; G. Comi; H.P. Hartung; L. Kappos; B. Khatri; X. Montalban; J. Pelletier; T. Stites; S. Wu; J. Jin; B. Eckert

Oral Fingolimod (FTY720) Treatment Improves the Performance of Daily Activities Compared with Intramuscular Interferon beta-1a: Patient-Reported Indices for Multiple Sclerosis (PRIMUS)-Activities Results from a Phase III Study (TRANSFORMS)

J. Cohen, F. Barkhof, G. Comi, H.P. Hartung, L. Kappos, B. Khatri, X. Montalban, J. Pelletier, T. Stites, S. Wu, J. Jin, B. Eckert

Radiology and Nuclear Medicine (VUmc)

Research output: Contribution to journal › Meeting Abstract › Other research output

Original language	English
Pages (from-to)	A543-A544
Journal	Neurology
Volume	74
Issue number	9
Publication status	Published - 2010

Cite this

Cohen, J., Barkhof, F., Comi, G., Hartung, H. P., Kappos, L., Khatri, B., Montalban, X., Pelletier, J., Stites, T., Wu, S., Jin, J., & Eckert, B. (2010). Oral Fingolimod (FTY720) Treatment Improves the Performance of Daily Activities Compared with Intramuscular Interferon beta-1a: Patient-Reported Indices for Multiple Sclerosis (PRIMUS)-Activities Results from a Phase III Study (TRANSFORMS). Neurology, 74(9), A543-A544.

@article{76b820314bb543ebb2516a6da2c12857,

title = "Oral Fingolimod (FTY720) Treatment Improves the Performance of Daily Activities Compared with Intramuscular Interferon beta-1a: Patient-Reported Indices for Multiple Sclerosis (PRIMUS)-Activities Results from a Phase III Study (TRANSFORMS)",

author = "J. Cohen and F. Barkhof and G. Comi and H.P. Hartung and L. Kappos and B. Khatri and X. Montalban and J. Pelletier and T. Stites and S. Wu and J. Jin and B. Eckert",

year = "2010",

language = "English",

volume = "74",

pages = "A543--A544",

journal = "Neurology",

issn = "0028-3878",

publisher = "American Academy of Neurology",

number = "9",

}

Cohen, J, Barkhof, F, Comi, G, Hartung, HP, Kappos, L, Khatri, B, Montalban, X, Pelletier, J, Stites, T, Wu, S, Jin, J & Eckert, B 2010, 'Oral Fingolimod (FTY720) Treatment Improves the Performance of Daily Activities Compared with Intramuscular Interferon beta-1a: Patient-Reported Indices for Multiple Sclerosis (PRIMUS)-Activities Results from a Phase III Study (TRANSFORMS)', Neurology, vol. 74, no. 9, pp. A543-A544.

Oral Fingolimod (FTY720) Treatment Improves the Performance of Daily Activities Compared with Intramuscular Interferon beta-1a: Patient-Reported Indices for Multiple Sclerosis (PRIMUS)-Activities Results from a Phase III Study (TRANSFORMS). / Cohen, J.; Barkhof, F.; Comi, G. et al.
In: Neurology, Vol. 74, No. 9, 2010, p. A543-A544.

Research output: Contribution to journal › Meeting Abstract › Other research output

TY - JOUR

T1 - Oral Fingolimod (FTY720) Treatment Improves the Performance of Daily Activities Compared with Intramuscular Interferon beta-1a: Patient-Reported Indices for Multiple Sclerosis (PRIMUS)-Activities Results from a Phase III Study (TRANSFORMS)

AU - Cohen, J.

AU - Barkhof, F.

AU - Comi, G.

AU - Hartung, H.P.

AU - Kappos, L.

AU - Khatri, B.

AU - Montalban, X.

AU - Pelletier, J.

AU - Stites, T.

AU - Wu, S.

AU - Jin, J.

AU - Eckert, B.

PY - 2010

Y1 - 2010

M3 - Meeting Abstract

SN - 0028-3878

VL - 74

SP - A543-A544

JO - Neurology

JF - Neurology

IS - 9

ER -